tirzepatide surmount-1 percent weight loss 72 weeks Trial SURMOUNT-1: Tirzepatide Drastically Reduces Weight
Description
Mounjaro is suitable for adults with a BMI of 30 kg/m or higher, or 27 kg/m or higher with weight-related health conditions such as type 2 diabetes or hypertension
No appointment needed
This is when moderate, informed drinking is most feasible
The specific programs and eligibility criteria change, so checking the manufacturer website directly provides the most current information
Blood Pressure Reduction (SURMOUNT-1) Krumholz HM, de Lemos JA, Sattar N, et al
Not everyone experiences the same timeline
